Declaration of the 11th ministerial-level PAC meeting in Berlin 2015 From strategies to action – how to tackle the challenges of Antimicrobial Resistance.

Slides:



Advertisements
Similar presentations
STRENGTHENING FINANCING FOR DEVELOPMENT: PROPOSALS FROM THE PRIVATE SECTOR Compiled by the UN-Sanctioned Business Interlocutors to the International Conference.
Advertisements

Standards and Trade Development Facility (STDF) A joint initiative in SPS capacity building and technical cooperation OIE Global Conference on Veterinary.
Thailand National Focal Point for IFCS Chemical Safety Section Food and Drug Administration Ministry of Public Health July 2003.
Antimicrobial resistance “One health fits all”
Essential Drugs Programme
A Common Immigration Policy for Europe Principles, actions and tools June 2008.
Cross Border Animal Health Plan of Action – Kenya and Uganda Four Strategic areas 1. To improve prevention, management and control of cross border animal.
GETTING READY FOR DUAL EMTCT VALIDATION IN THE AMERICAS Adele Schwartz Benzaken.
O F F I C E O F T H E Auditor General of British Columbia 1 OAG Review of the Performance Agreements between MoHS and Health Authorities.
FLLLEX – Final Evaluation
Toolkit for Mainstreaming HIV and AIDS in the Education Sector Guidelines for Development Cooperation Agencies.
Coordination Page Multi-Sectoral, Coordinated Action General coordination responsibilities of a multi- sectoral and community-based approach include:
PACIFIC AID EFFECTIVENESS PRINCIPLES. Purpose of Presentation Provide an overview of Pacific Principles on Aid Effectiveness Provide an overview of Pacific.
April_2010 Partnering initiatives at country level Proposed partnering process to build a national stop tuberculosis (TB) partnership.
Strategy and Policy Cohesion: “The One Health Agenda: will it deliver” Elizabeth J. Phillips, MD, FRCPC,FRACP, FACTM Professor & Director, Centre for Clinical.
Land Governance and Security of Tenure in Developing Countries White paper of the French Development cooperation LAND POLICIES AND MDGS IN RESPONSE TO.
DETERMINE Working document # 4 'Economic arguments for addressing social determinants of health inequalities' December 2009 Owen Metcalfe & Teresa Lavin.
Background Nature and function Rationale Opportunities for TB control Partnering process.
Towards a National Alliance against Chronic Respiratory Diseases Nikolai Khaltaev, MD, PhD March 2006, GARD General Meeting, Beijing, China.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
Fifth Session of the Islamic Conference of Health Ministers Panel Discussion IV: NGO Involvement in the Improvement of Health Services in OIC Member Countries.
The AMR One Health Policy Toolkit: Animal - Human Interface Dr Mark Schipp December 2014.
ESPON Seminar Luxembourg, 8-9 December Cohesion-and-Urban-Policy-_26-27-November-2015_-Luxembourg-City_/index.php.
NFPs at the 4th Ministerial Conference Peter Mayer Vienna, COST E19, September 2003.
EC actions against the rising threats from Antimicrobial Resistance
Public health, innovation and intellectual property 1 |1 | The Global Strategy on Public Health, Innovation and Intellectual Property Technical Briefing.
Waisea Vosa Climate Change Unit Division of Political and Treaties Ministry of Foreign Affairs and International Cooperation.
Sustainable Development Tools and the SD Initiative in the Arab Region (SDIAR) Presentation: Hend Zaki.
Future needs for capacity building and recommendations to the OIE Dr Sarah Kahn Consultant to the OIE
Ministerial Declaration and Concluding Remarks MD PhD Karin Tegmark Wisell Chair AMR expert group, NDPHS.
1 Outcome of the 4 th Global Animal Health Conference (GAHC) June 2015 Bettye K. Walters, DVM US Food and Drug Administration
Kerstin Ödman Chair of the Strategy Working Group Ad hoc NDPHS Strategy Working Group Report for the NDPHS committee of Senior Representatives Riga,
Dr Marja Anttila, SWG Chair Finland 11 th Partnership Annual Conference, Berlin, NDPHS Strategy 2020 and Action Plan.
2007 Pan American Health Organization 2004 Pan American Health Organization Malaria in the Americas: Progress, Challenges, Strategies and Main Activities.
Development Account: 6th Tranche Strengthening the capacity of National Statistical Offices (NSOs) in the Caribbean Small Island Developing States to fulfill.
Project: EaP countries cooperation for promoting quality assurance in higher education Maria Stratan European Institute for Political Studies of Moldova.
Northern Dimension Antibiotic Resistance Study NoDARS Prof Jaana Vuopio, M.D., Ph.D., PAC 11 side-event, 19 November 2015, Berlin, Germany.
1 The contribution of VICH to the global One Health approach VICH5 CONFERENCE, OCTOBER 2015, TOKYO Jean-Pierre Orand, Anses, France, OIE Collaborating.
NDPHS Work Plan for 2010 Hilde C. Sundrehagen CSR Chair NDPHS Partnership Annual Conference Oslo, 25 November 2009 NDPHS Work Plan for 2010.
Dr Wiktor Szydarowski Freelance consultant NDPHS SWG meeting Stockholm, 10 February 2015 Progress in developing the NDPHS Strategy 2020.
WHO Regional Office for Europe
WHO’s policy priorities and projects
General Situation (Overview)
Call for Action & International Initiative
Capacity Development 4.0 Andrea Pellandra
EU Strategy for the Baltic Sea Region
Implementation of 2016 Work Plan ASA EG
Accreditation Canada Medicine Accreditation 2016.
Technical Cooperation Section SEDI- Executive Office
Lecture 9: PHC As a Strategy For HP Dr J. Sitali
UN REDD FAO-UNDP-UNEP July 2008
Maximizing the value and the impact of health research in Europe
Advancing South-South Cooperation for Effective Implementation of
Antibiotic Resistance: Strategic Solutions
“An overview” 10th April 2018 at MOH SMT Now 27th April 2018 at NPHIL
Statistics Governance and Quality Assurance: the Experience of FAO
Partnerships and networks
SRH & HIV Linkages Agenda
Access to HIV/AIDS Medicines The 3x5 strategy
…and still actual for a post-2010 strategy!
Strategy and Policy Cohesion: “The One Health Agenda: will it deliver”
Essential Drugs and Medicines Policy
National Cancer Center
Furthering the Field GROWING THE MOVEMENT
Essential Drugs and Medicines Policy
Marleen De Smedt Geoffrey Thomas Cynthia Tavares
Millennium Development Goals (MDGs)
Policy-to-project-to-policy Conference
UNDP Asia Pacific Regional Centre August 2010
National one Health Strategy( )
Presentation transcript:

Ministerial Declaration MD PhD Karin Tegmark Wisell, Chair AMR expert group, NDPHS  

Declaration of the 11th ministerial-level PAC meeting in Berlin 2015 From strategies to action – how to tackle the challenges of Antimicrobial Resistance (AMR) in the Northern Dimension Region

Recognition We, the partner countries and organizations of the Northern Dimension Partnership in Public Health and Social Well-being (NDPHS) that have adopted this declaration, acknowledge that the growing antimicrobial resistance (AMR) in microorganisms is an increasing global health problem and a challenge to our societies.

Recognition, cont. We recognize that AMR is a multi-sectorial problem, involving human and veterinary medicine, agriculture, the food industry and the environment and that it is a problem that can only be solved through international collaboration. We therefore strongly support the direction taken by the WHO European strategic action plan on antibiotic resistance (EUR/RC61/14) from 2011, and the newly launched WHO Global action plan on antimicrobial resistance by (A68/20), in taking the one-health approach into account and providing the frame for further action. The Global action plan on antimicrobial resistance is a leading document to guide development of comprehensive national strategies to fight AMR. We also welcome the development of key indicators by WHO to have valid measurements to benchmark the implementation of the Global action plan on antimicrobial resistance. Another highly important initiative is the G7 Health Ministers Berlin Declaration on Antimicrobial Resistance –Global Union for Antibiotics Research and Development (GUARD).

Recognition, cont. We note with satisfaction that the majority of the NDPHS countries have guidelines in place on rational use of antimicrobials and infection prevention and control. However, we are aware that further evaluation of the implementation, use and impact of these guidelines is crucial.

Recognition, cont. It is of some concern that within the Northern Dimension area, there is great variation in the availability and quality of surveillance data on antimicrobial resistance and antibiotic consumption. Lack of comparable data on the prevalence of AMR and usage of antibiotics in the population, both within, but also between the partnership countries, results in an incomplete understanding of the regional antibiotic resistance situation and one of the consequences being difficulties in guiding empiric treatment decision. The lack of uniformity in surveillance methods, sampling techniques and standardization of laboratory procedures hampers research on epidemiology as well as other issues. As a response to these gaps the development and implementation of the Northern Dimension Antibiotic Resistance Study (NoDARS), an ongoing example in the Northern Dimension area that addresses many of the challenges listed above, is therefore much welcomed and demonstrate that investment into research is a key element of the fight against AMR.

Recognition, cont. We recognize that there is need for increased knowledge among health care providers and better awareness in the general public on the impact of AMR on public health. Finally, we wish to emphasize that we are humble to the fact that due to the complexity of the AMR problem there are many different ways in which to meet the challenge. Addressing AMR requires an intersectoral approach, involving all organizational levels and adapted to individual circumstances. We recognize that all countries need to take action to combat AMR, and hereby declare our support for the many people who work with this issue on a daily basis, on a research, a health care, a governmental or a policy level.

Commitment We, the partners will encourage, provide political support and facilitate the exchange of relevant information and experience among experts and between policy and decision makers. We will work towards strengthening the coordination of activities between relevant sectors by bringing together high- level experts from national ministries and agencies, medical and veterinary institutions, the research community, NGOs and other relevant parties in the partner countries and organizations.

Commitment, cont. We encourage all partners to update and implement a comprehensive strategy to fight AMR in line with the WHO Global action plan on antimicrobial resistance. We will strengthen the one-health approach, tackling all areas alike (human- and animal health, food and agriculture) and strive to preserve the use of antimicrobials only for the purpose of medical treatment after appropriate diagnostics. We will explore reasons for the delivery of antibiotics without prescriptions, obstacles for diagnostic procedures to better secure appropriate use.

Commitment, cont. We will encourage wider participation by relevant national authorities in already existing and new internationally agreed surveillance systems, for easier comparison and better understanding of the AMR problem. This includes EARS-net, CAESAR and the WHO global surveillance systems (GLASS), among other international surveillance mechanisms such as OIE and FAO. We will actively support exchange of knowledge between experts in the Northern Dimension countries to ease the development and implementation of key indicators for rational use of antibiotics and guidelines regarding rational use and infection prevention and control programmes

Commitment, cont. We will facilitate efforts to increase the capacity of health care providers and will support the efforts being made by representatives of the NDPHS in reaching out to the general public with information on AMR and its impact. Cohesive implementation of shared policy recommendations, mentioned above, is important for the future work in the Northern Dimension region. We will therefore work to ease the processes in our respective nations. By this, we declare that we, through the NDPHS, by all available means, support the facilitation of cooperation through joint international activities that will be adapted to the prevailing situation in the countries of the Northern Dimension.